NEW YORK, Oct. 8, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $91.8 billion as of September 30, 2024, an increase of $3.7 billion from assets under management of $88.1 billion at August 31, 2024. The increase was due to market appreciation of $2.6 billion and net inflows of $1.3 billion, partially offset by distributions of $286 million. Assets Under Management (unaudited) | --- | --- | --- | --- | --- | --- | |------------------------------|-- ...

Study shows the repeated long-term, as-needed use of STS101 for the acute treatment of a migraine attack demonstrated a favorable safety profile and was well tolerated. Exploratory Efficacy Endpoints showed that STS101provided rapid freedom from pain (37% of attacks), and rapid freedom from most bothersome symptoms (54% of attacks) at 2 hours and sustained treatment benefits over 48 hours after dosing. DURHAM, N.C., Oct. 8, 2024 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical c ...

Total Orders for 2024 Reach $20.2 Million LONDON, Oct. 8, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, today announced it has secured $6 million in new orders during the third quarter of 2024. This strong close continues the company's customer acquisition momentum and brings Corero's total orders for 2024 to $20.2 million. Corero's innovative SmartWall ONE™ DDoS protection solutions have driven the company's expansio ...

VANCOUVER, British Columbia and BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced its participation in the upcoming BofA Securities 2024 CNS Therapeutics Virtual Conference taking place October 7, 2024. Fireside Chat Presentation Details: Date: Monday, October 7, 2024 Time: 11:40 am Eastern Time Webcast: Regis ...

CORAL GABLES, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst's management team, will participate in the upcoming BofA Securities CNS Therapeutics Virtual Confer ...

NEW YORK, Sept. 30, 2024 /PRNewswire/ -- The Boards of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for October, November, and December 2024, as summarized in the charts below: ______________________________________________________________________________ | --- | --- | --- | |--------------|--------------------------------------------------------------------|----------------------------| | Ticker \nFOF | Fund Name \nCohen & Steers Closed-End Opportunity Fund, In ...

NEWTON, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer's disease, announced today that management will participate in a fireside chat at the Bank of America CNS Therapeutics Virtual Conference on Monday, Oct. 7, 2024, at 8:00 a.m. ET. The live webcast may be accessed under the Investors tab on www.acumenpharm.com an ...

LONDON, Sept. 24, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, will hold investor calls this week to discuss its unaudited results for the six months ended 30 June 2024. The calls will be led by Corero's CEO, Carl Herberger, and newly appointed CFO, Chris Goulden, and will provide insight into the company's financial performance, strategic initiatives, and outlook for the remainder of the year. Corero's H1 2024 resul ...

NEW YORK, Sept. 12, 2024 /PRNewswire/ -- SUBSCRIBE, a leading operating system for alternative investments serving institutional investors, wealth management firms, and fund managers, announced today that leading real assets investment manager Cohen & Steers (NYSE: CNS) has joined the SUBSCRIBE platform to offer its private real estate strategies. The implementation of a centralized operating system will streamline investment and operational processes for clients in the private wealth channel while expandin ...

NEW YORK, Sept. 10, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $88.1 billion as of August 31, 2024, an increase of $3.5 billion from assets under management of $84.6 billion at July 31, 2024. The increase was due to market appreciation of $3.7 billion and net inflows of $8 million, partially offset by distributions of $152 million. Assets Under Management (unaudited) | --- | --- | --- | --- | --- | --- | |------------------------------|------- ...